Oral News and Research

RSS

P&G fourth quarter net sales increase 10% to $20.9 billion

The Procter & Gamble Company net sales grew 10 percent to $20.9 billion for the fourth quarter and five percent to $82.6 billion for fiscal 2011.

5 Aug 2011

Appeals court tosses out health challenge brought by New Jersey docs

A U.S. appeals court rejected a bid by group of New Jersey doctors to reinstate their lawsuit challenging the federal health-insurance overhaul. New Jersey Physicians Inc., a nonprofit group, and an uninsured patient identified only as "Patient Roe" failed to adequately plead a concrete or actual injury, the U.S. Court of Appeals in Philadelphia ruled today.

5 Aug 2011

ArQule second quarter net loss increases to $10,804,000

ArQule, Inc. today announced its financial results for the second quarter of 2011.

4 Aug 2011

Boston Therapeutics files chewable metformin ANDA with FDA to treat diabetes

Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, today announced that it has submitted an Abbreviated New Drug Application (ANDA) for chewable metformin with the U.S. Food and Drug Administration.

4 Aug 2011

Avaxia receives BARDA contract to develop new radiation mitigation drug

Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today it was awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA), for the research and development of an oral antibody therapy to mitigate the gastrointestinal damage that follows radiation exposure that might occur after a nuclear incident.

4 Aug 2011

Bad teeth in Ozzie kids worries dental health experts

According dental health experts, changes in diet, un-flouridated bottled water and the habit of “constantly bathing” ones teeth in sugary drinks is to blame for the rising number of decaying and rotten teeth found in children

4 Aug 2011

ImmunoGen revenues increase to $19.3 million for fiscal year 2011

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today reported financial results for the three-month period and fiscal year ended June 30, 2011.

4 Aug 2011

Alcohol, tobacco use increase risk of upper aero-digestive tract cancers

Upper aero-digestive tract cancers (UADT), especially those of the oral cavity, pharynx, and larynx, are often referred to as alcohol-related cancers as it has been shown repeatedly that heavy drinkers, in particular, are at increased risk.

3 Aug 2011

N.Y. brothers make good money running nonprofit group to help disabled; Fla. sends Medicaid plan to feds

The New York Times details a the expensive lifestyle of two men from Brooklyn who earned nearly $1 million a year when running a Medicaid-financed nonprofit organization serving the developmentally disabled. Meanwhile, in Florida, state officials submitted their plans for converting Medicaid to a managed care program.

3 Aug 2011

A guide to safe and informed recovery after prostate cancer

Prostate cancer is the number two killer of American men, second only to lung cancer. It is a disease that affects more than 2 million American men, and in 2010 there were over 218,000 new diagnoses.

2 Aug 2011

ARIAD reports $47.8 million net loss for second quarter 2011

ARIAD Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2010 and provided an update on corporate developments.

2 Aug 2011

Rigel reports net loss of $21.5 million for second quarter 2011

Rigel Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2011.

2 Aug 2011

Coast Dental acquires SmileCare

Coast Dental Services, Inc., has completed the acquisition of the assets of Dental Technology, Inc. (DTI), doing business as SmileCare, and Community Dental Services, Inc., a California licensed health care service plan.

2 Aug 2011

Teva's ZOELY oral contraceptive receives EU Marketing Authorization

Teva Pharmaceutical Industries Ltd announced today that its new oral contraceptive, ZOELY, has received a Marketing Authorization in the European Union (EU) for the prevention of pregnancy.

2 Aug 2011

Can-Fite commences CF101 phase 2/3 trial for treatment of Psoriasis

Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, ophthalmic, and liver diseases, traded on the Tel Aviv Stock Exchange announced today that it has commenced patient enrolment in a phase 2/3 clinical trial of CF101 for the treatment of Psoriasis.

2 Aug 2011

FDA approves Covidien's morphine sulfate oral solution for chronic pain in opioid-tolerant patients

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) recently granted approval to the company's Mallinckrodt business for morphine sulfate oral solution, used to relieve moderate to severe acute and chronic pain in opioid-tolerant patients. The solution will be available as a generic in 100 milligrams per 5 mL (20 milligrams per 1 mL).

1 Aug 2011

Merck submits ridaforolimus MAA with EMA for treatment of metastatic soft-tissue, bone sarcomas

ARIAD Pharmaceuticals, Inc. today announced that its ridaforolimus partner, Merck, has submitted a marketing authorization application (MAA) for ridaforolimus with the European Medicines Agency.

1 Aug 2011

Accuray to showcase CyberKnife, TomoTherapy systems at AAPM/COMP meeting

Accuray Incorporated, the premier radiation oncology company, announced today that it will showcase the CyberKnife Robotic Radiosurgery System and the TomoTherapy Radiation Therapy Treatment System in the company's booths at the 2011 Joint American Association of Physicists in Medicine (AAPM)/Canadian Organization of Medical Physicists (COMP) Meeting.

1 Aug 2011

Helios Scholars Program at TGen strengthens biomedical education

Tomorrow's leaders in science and medicine graduate Friday from the biomedical summer internship program at the Translational Genomics Research Institute.

30 Jul 2011

New Aspen Dental office to open in Springdale

Patients looking for a dentist in Springdale, OH now have a new dental care provider option with the opening of a new Aspen Dental office this month. The new practice, which opens on August 4th at 25 East Kemper Road, will provide dental services that range from dentures and preventive care to general dentistry and restoration.

30 Jul 2011